Named on one round in the feed.
Since 2023-01-31
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Colossal Biosciences Colossal sells advanced genetics and biosciences solutions focused on de-extinction and conservation efforts for endangered species. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2023-01-31 | [ PART ] |